Nadim Yared is a consummate networker. Indeed, the device industry entrepreneur who leads private Minneapolis-based CVRx Inc. has a lot to network about, as he stewards Barostim therapy for the treatment of chronic heart failure and hypertension onto the US and EU markets.
There, and once established, he is confident that the heart failure device (the first intended application of which was hypertension)...